Sales and Marketing

The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …

MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …

Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …

Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …

Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …

RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …